CVS Health Corp (BSP:CVSH34)
R$ 31.75 -0.09 (-0.28%) Market Cap: 403.33 Bil Enterprise Value: 794.75 Bil PE Ratio: 9.69 PB Ratio: 0.92 GF Score: 76/100

CVS Health Corp at Bank of America Healthcare Conference Transcript

May 12, 2022 / 03:40PM GMT
Release Date Price: R$50.54 (-0.19%)
Michael Aaron Cherny
BofA Securities, Research Division - Director

Everyone, thanks for joining us for this session of day 3 of the BofA Healthcare Conference. I'm Mike Cherny, the health care tech and distribution analyst. It's my pleasure to have CVS Health with us today, Shawn Guertin, CFO. Tom Cowhey runs capital markets also is here as well.

We have no slides, so we're going to try and keep this as an informal conversation. I don't know at least in reported earnings, anything that stood out you want to make sure we got across before we jumped in?

Shawn Michael Guertin
CVS Health Corporation - Executive VP & CFO

I would say it was really a very good quarter, a really good start to the year. All of our businesses were largely in line with where we expected them to be. We understood whatever variations were there. So obviously, still a lot to play out for 2022. And obviously, just like everyone, we're all still trying to sort of navigate the COVID trajectory of things and the ups and downs around that. But overall, it was really an excellent

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot